[
  {
    "ts": null,
    "headline": "Enbridge: \"Quintuple Vortex\" Exemplified",
    "summary": "Enbridge fails key quality metrics: high debt, slow growth, high capex, unsustainable dividends, and significant shareholder dilution create a...",
    "url": "https://finnhub.io/api/news?id=67bc5dc57d65348054bae9585774b4cb470951dd89e9ae12ce4615b5012b5d9c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749037523,
      "headline": "Enbridge: \"Quintuple Vortex\" Exemplified",
      "id": 135010682,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1249580599/image_1249580599.jpg?io=getty-c-w1536",
      "related": "ARE",
      "source": "SeekingAlpha",
      "summary": "Enbridge fails key quality metrics: high debt, slow growth, high capex, unsustainable dividends, and significant shareholder dilution create a...",
      "url": "https://finnhub.io/api/news?id=67bc5dc57d65348054bae9585774b4cb470951dd89e9ae12ce4615b5012b5d9c"
    }
  },
  {
    "ts": null,
    "headline": "Alexandria Real Estate: Now Too Cheap To Ignore, With Just ~1% Annual Growth Priced In",
    "summary": "Alexandria Real Estate (ARE) looks undervalued, offering a 7.5% dividend yield and trading at a low forward price/FFO ratio of 7.6x.",
    "url": "https://finnhub.io/api/news?id=8fae2e6a3fc6c4a13704764c86e1bc6bd885a231708d6d9ee34e2f563b85b06c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749026700,
      "headline": "Alexandria Real Estate: Now Too Cheap To Ignore, With Just ~1% Annual Growth Priced In",
      "id": 135008750,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1409383663/image_1409383663.jpg?io=getty-c-w1536",
      "related": "ARE",
      "source": "SeekingAlpha",
      "summary": "Alexandria Real Estate (ARE) looks undervalued, offering a 7.5% dividend yield and trading at a low forward price/FFO ratio of 7.6x.",
      "url": "https://finnhub.io/api/news?id=8fae2e6a3fc6c4a13704764c86e1bc6bd885a231708d6d9ee34e2f563b85b06c"
    }
  },
  {
    "ts": null,
    "headline": "Very Bad News For REITs: The Trade War Is Back",
    "summary": "The trade war could have an impact on REITs, given the turmoil could send interest rates higher. Read why there's a silver lining for long-term REIT investors.",
    "url": "https://finnhub.io/api/news?id=d3e265a6a829f4ed5500fed56c52d4a8ed1784353d9fec5228d60d648d514b4b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749024900,
      "headline": "Very Bad News For REITs: The Trade War Is Back",
      "id": 135008392,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/174071285/image_174071285.jpg?io=getty-c-w1536",
      "related": "ARE",
      "source": "SeekingAlpha",
      "summary": "The trade war could have an impact on REITs, given the turmoil could send interest rates higher. Read why there's a silver lining for long-term REIT investors.",
      "url": "https://finnhub.io/api/news?id=d3e265a6a829f4ed5500fed56c52d4a8ed1784353d9fec5228d60d648d514b4b"
    }
  },
  {
    "ts": null,
    "headline": "Alexandria Real Estate: It's The Best Time Ever To Buy This 7%+ Yield",
    "summary": "Alexandria Real Estate: It's The Best Time Ever To Buy This 7%+ Yield",
    "url": "https://finnhub.io/api/news?id=4f202d3f44fc445bf6fe976809b48fe4b69408d25b7e33a69ff2b18514892c7f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749022200,
      "headline": "Alexandria Real Estate: It's The Best Time Ever To Buy This 7%+ Yield",
      "id": 135008007,
      "image": "",
      "related": "ARE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4f202d3f44fc445bf6fe976809b48fe4b69408d25b7e33a69ff2b18514892c7f"
    }
  },
  {
    "ts": null,
    "headline": "HAYA Therapeutics Moves San Diego Operations to Lilly Gateway Labs to Accelerate Development of RNA-Guided Therapeutics Platform",
    "summary": "LAUSANNE, SAN DIEGO, USA - HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare,...",
    "url": "https://finnhub.io/api/news?id=96171ce638a07b9b271b8d05e8f7ae8a612c9e8571fdab7a3a98d15e75e8bb68",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749019168,
      "headline": "HAYA Therapeutics Moves San Diego Operations to Lilly Gateway Labs to Accelerate Development of RNA-Guided Therapeutics Platform",
      "id": 135007524,
      "image": "",
      "related": "ARE",
      "source": "Finnhub",
      "summary": "LAUSANNE, SAN DIEGO, USA - HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare,...",
      "url": "https://finnhub.io/api/news?id=96171ce638a07b9b271b8d05e8f7ae8a612c9e8571fdab7a3a98d15e75e8bb68"
    }
  }
]